Ratish Krishnan

Senior Strategy Consultant

Ratish Krishnan is a Senior Strategy Consultant in the Novel Modalities BioProcessing group for the Americas. He is passionate about providing solutions to bring treatments to market. A Process Development Scientist by background, he has over 13 years of experience in vaccine, monoclonal antibodies and viral vector modalities from pre-clinical to late stage process characterization, validation and commercialization activities such as BLA authoring.

Breaking perceptions of TFF in gene therapy manufacturing

The tangential flow filtration (TFF) unit operation in viral vector manufacturing is a critical step on the path…

Innovative Trends That Drive AAV Capture and Empty-Full Separation

Ratish Krishnan and Oliver Rammo share their thoughts on the need for a more nuanced understanding of AAV…

Scroll to Top